ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Iridium(III) complex induces apoptosis in HeLa cells by regulating mitochondrial and PI3K/AKT signaling pathways: In vitro and in vivo experiments

He, Shu-fen; Han, Wei-chao; Shao, Ying-ying; Zhang, Han-bin; Hong, Wen-xin; Yang, Qiu-hong; Zhang, Yu-qing; He, Rui-rong*; Sun, Jing*广东医学院; 南方医科大学; 东莞市人民医院
Bioorganic Chemistry2023-12DOI: 10.1016/j.bioorg.2023.106867
5阅读
引用收藏
分享

摘要

Cyclometalated iridium complexes with mitochondrial targeting show great potential as substitutes for platinum-based complexes because of their strong anti-cancer properties. Three novel cyclometalated iridium(III) com-pounds were synthesized and evaluated in five different cell lines as part of the ongoing systematic investigations of these compounds. The complexes were prepared using 4,7-dichloro-1,10-phenanthroline ligands. The cyto-toxicity of complexes Ir1-Ir3 towards HeLa cells was shown to be high, with IC50 values of 0.83 +/- 0.06, 4.73 +/- 0.11, and 4.95 +/- 0.62 mu M, respectively. Complex Ir1 could be ingested by HeLa cells in 3 h and has shown high selectivity toward mitochondria. Subsequent investigations demonstrated that Ir1 triggered apoptosis in HeLa cells by augmenting the generation of reactive oxygen species (ROS), reducing the mitochondrial membrane potential, and depleting ATP levels. Furthermore, the movement of cells was significantly suppressed and the progression of the cell cycle was arrested in the G0/G1 phase following the administration of Ir1. The Western blot analysis demonstrated that the induction of apoptosis in HeLa cells by Ir1 involves the activation of the mitochondria-dependent channel and the PI3K/AKT signaling pathway. No significant cytotoxicity was observed in zebrafish embryos at concentrations less than or equal to 16 mu M, e.g., survival rate and developmental ab-normalities. In vivo, antitumor assay demonstrated that Ir1 suppressed tumor growth in mice. Therefore, our work shows that complex Ir1 could be a promising candidate for developing novel antitumor drugs.

学科与关键词

关键词
Iridium(III) complexCancerMitochondriaApoptosisPI3K/AKT
相关
加载中…
  • Iridium (III) complexes induce cervical carcinoma apoptosis via disturbing cellular redox homeostasis disorder and inhibiting PI3K/AKT/mTOR pathway
    Hao, Jing; Liu, Haimei; Wang, Jiawen; Wang, Xiuzhen*; Huang, Chunxia; Liang, Lijuan; Chen, Jing; Wang, Yi; Liu, Yunjun*Journal of Inorganic Biochemistry, 2022, 235: 111946.被引 7
  • Iridium(III) complexes inhibit the proliferation and migration of BEL-7402 cells through the PI3K/AKT/mTOR signaling pathway
    Chen, Jing; Liu, Haimei; Chen, Yichuan; Hu, Huiyan; Huang, Chunxia; Wang, Yi; Liang, Lijuan; Liu, Yunjun*Journal of Inorganic Biochemistry, 2023, 241: 112145.被引 3
  • Synthesis, Characterization and Anticancer Efficacy Studies of Iridium (III) Polypyridyl Complexes against Colon Cancer HCT116 Cells
    Xie, Biao; Wang, Yi; Wang, Di; Xue, Xingkui; Nie, Yuqiang*MOLECULES, 2022, 27(17): 5434.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Bioorganic Chemistry
发表日期
2023-12
卷期
第 141 卷
页码
106867
DOI
10.1016/j.bioorg.2023.106867
语言
ENGLISH
成果收录
SCIE
资助标注
Dongguan Science and Technology of Social Development Program [20211800905242, 20231800935722]; Project of Scientific Research Development Fund of Dongguan People's Hospital [K202015]; Traditional Chinese Medicine Research Project Foundation of Guangdong Province [20221415]; Research Foundation of Guangdong Hospital Pharmacy Association (Aomei Foundation) [2022A17]

作者

  • H

    He, Shu-fen (第一作者)

    dongguan peoples hosp · southern med univ

  • H

    Han, Wei-chao

    dongguan peoples hosp · southern med univ

查看全部 9 位作者收起作者
  • S

    Shao, Ying-ying

    dongguan peoples hosp · southern med univ

  • Z

    Zhang, Han-bin

    dongguan peoples hosp · southern med univ

  • H

    Hong, Wen-xin

  • Y

    Yang, Qiu-hong

    dongguan peoples hosp · southern med univ

  • Z

    Zhang, Yu-qing

    guangdong med univ

  • H

    He, Rui-rong (通讯)

    dongguan peoples hosp · southern med univ

  • S

    Sun, Jing (通讯)

    guangdong med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417